Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
Open Access
Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
Norimitsu Kasahara
Norimitsu Kasahara
,
Hisao Imai
Hisao Imai
,
Kyoichi Kaira
Kyoichi Kaira
,
Keita Mori
Keita Mori
,
Kazushige Wakuda
Kazushige Wakuda
,
Akira Ono
Akira Ono
,
Tetsuhiko Taira
Tetsuhiko Taira
,
Hirotsugu Kenmotsu
Hirotsugu Kenmotsu
,
Hideyuki Harada
Hideyuki Harada
,
Tateaki Naito
Tateaki Naito
,
Haruyasu Murakami
Haruyasu Murakami
,
Masahiro Endo
Masahiro Endo
,
Takashi Nakajima
Takashi Nakajima
,
Masanobu Yamada
Masanobu Yamada
and
Toshiaki Takahashi
Toshiaki Takahashi
| Nov 27, 2015
Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Nov 27, 2015
Page range:
409 - 415
Received:
Jan 31, 2015
Accepted:
Jul 06, 2015
DOI:
https://doi.org/10.1515/raon-2015-0037
Keywords
chemoradiotherapy
,
limited-stage disease small cell lung cancer
,
overall survival
,
post-progression survival
,
progression-free survival
© 2015 Norimitsu Kasahara et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.